The multidisciplinary team for gastroenteropancreatic neuroendocrine tumours: the radiologist's challenge

V Granata, R Fusco, SV Setola… - Radiology and …, 2019 - sciendo.com
… The neuroendocrine tumour of the gastroenterict tract can cause vague abdominal symptoms
and may be diagnosedtumour and the availability of specialized imaging techniques and …

Endoscopic ultrasonography of neuroendocrine tumours

T Zimmer, H Scherübl, S Faiss, U Stölzel, EO Riecken… - Digestion, 2000 - karger.com
… for pituitary tumour disease by determination of serum prolactin hormone levels. The various
imaging techniques were compared for their diagnostic efficacy in localizing tumours and …

SPECT/CT hybrid imaging with 111In‐pentetreotide in assessment of neuroendocrine tumours

Y Krausz, Z Keidar, I Kogan, E Even‐Sapir… - Clinical …, 2003 - Wiley Online Library
… or diagnosed neuroendocrine tumours, SPECT/CT appears to further increase the diagnostic
accuracy … Furthermore, in the present study group, SPECT/CT imaging impacted on patient …

Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals

E Bombardieri, A Coliva, M Maccauro… - … Molecular Imaging, 2010 - search.proquest.com
… For example, in neuroendocrine tumours, a high uptake indicates a well-differentiated
histotype more likely to respond well to therapy, whereas a low uptake, or no uptake at all, is gener…

Gastroenteropancreatic neuroendocrine tumours

IM Modlin, K Oberg, DC Chung, RT Jensen… - The lancet …, 2008 - thelancet.com
tumours has increased substantially (figure 2), which may partly reflect increased diagnosis
… availability of advanced endoscopic and radiological imaging. Clinical behaviour of GEP …

18F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type

S Balogova, JN Talbot, V Nataf, L Michaud… - … and Molecular Imaging, 2013 - Springer
… positron emission tomography (PET) imaging which has been registered since 2006 in …
Neuroendocrine tumour (NET) imaging is part of its registered indications.NET functional imaging

Molecular imaging in diagnosis of neuroendocrine tumours

K Oberg - The Lancet Oncology, 2006 - thelancet.com
… -diethylenetriaminepentaacetate (DTPA)-octreotide was introduced for the diagnosis and
staging of neuroendocrine tumours, and this method is now used routinely in clinical practice. …

Imaging appearances of metastases from neuroendocrine tumours of the pancreas

MP Debray, O Geoffroy, JP Laissy… - The British journal of …, 2001 - academic.oup.com
… Metaiodobenzylguanidine (MIBG) scintigraphy, although contributive for various
neuroendocrine tumours, is less sensitive than SRS in diagnosing ETP and is not routinely used. …

Neuroendocrine tumours of the female genital tract: a case-based imaging review with pathological correlation

J Lopes Dias, TM Cunha, FV Gomes, C Callé… - Insights into imaging, 2015 - Springer
… There are no consistent data regarding the prognosis of non-pure NE endometrial
tumours; however, the cases we illustrate were diagnosed in advanced FIGO stages, IV-B (distant …

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours

GA Kaltsas, JJ Mukherjee, AB Grossman - Annals of Oncology, 2001 - Elsevier
… Both radionuclides may exert a complementary role in the imaging of neuroendocrine
tumours [13, 16], as occasionally scintigraphy with 123IMIBG may demonstrate uptake in non-…